Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Ethyl Acetate | HCID 8857 | — |
| Reactant | HCID 86620261 | HCID 86620261 | — |
| Solvent | Sulfuric Acid | HCID 1118 | — |
| Product | HCID 86620262 | HCID 86620262 | 108.6% |
Reaction Steps
Sulfonamide 215 (750 mg, 1.31 mmol) was cooled to 0° C., dissolved in conc. H2SO4 (20 mL) at 0° C., and the solution was stirred at this temperature for 2 h. Ice water and EtOAc were added and the mixture was extracted with EtOAc (×3). The combined extracts were washed with brine (×3), dried, and evaporated to give 1-chloromethyl)-3-(trifluoroacetyl)-1,2-dihydro-3H-benzo[e]indole-8-sulfonamide (216) (490 mg, 96%). A sample was recrystallised from CH2Cl2/EtOAc as yellow crystals: mp 229-231° C.; 1H NMR [(CD3)2SO] δ 8.45 (d, J=9.0 Hz, 1H), 8.42 (s, 1H), 8.21 (d, J=8.7 Hz, 1H), 8.11 (d, J=9.0 Hz, 1H), 7.87 (dd, J=8.7, 1.7H, 1H), 7.51 (s, 2H), 4.65-4.57 (m, 1H), 4.57-4.50 (m, 1H), 4.44 (d, J=10.8 Hz, 1H), 4.18 (dd, J=11.3, 3.1 Hz, 1H), 4.05 (dd, J=11.3, 5.9 Hz, 1H). Anal. (C15H12ClF3N2O3S.½H2O) C, H, N.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07718688B2 |
|---|
| Source dataset | uspto-grants-2010_05 |
|---|
| ORD ID | ord-b43bf0f27bfc4bf89ae996d421661b17 |
|---|
| Source note | uspto-grants-2010_05 |
|---|